An evaluation of styrene genotoxicity using several biomarkers in a 3- year follow-up study of hand-lamination workers

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 445, Issue 2, 1999, Pages 205-224

  Vodička, Pavel ^a   Tvrdik, Tatiana ^b   Osterman Golkar, Siv ^c   Vodičková, Ludmila ^d   Peterková, Kateřina ^a   Souček, Pavel ^d   Šarmanová, Jana ^d   Farmer, Peter B ^e   Granath, Fredrik ^b   Lambert, Bo ^b   Hemminki, Kari ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Biomarker; DNA adduct; Exposure indicator; Granulocyte; Haemoglobin adduct; HPRT mutant frequency; Lymphocyte; Mandelic acid; Single strand break in DNA; Styrene

Indexed keywords

DNA; HEMOGLOBIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MANDELIC ACID; STYRENE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA STRAND BREAKAGE; FEMALE; GENOTOXICITY; HUMAN; INDUSTRIAL WORKER; MALE; MUTATION; OCCUPATIONAL EXPOSURE; PLASTIC INDUSTRY; PRIORITY JOURNAL; SMOKING HABIT; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; BIOLOGICAL MARKERS; BREATH TESTS; COMET ASSAY; DNA ADDUCTS; DNA DAMAGE; DNA, SINGLE-STRANDED; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MANDELIC ACIDS; MIDDLE AGED; MUTATION; OCCUPATIONAL EXPOSURE; PLASTICS; REGRESSION ANALYSIS; STYRENE; T-LYMPHOCYTES; VALINE;

EID: 0032752780     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00127-8     Document Type: Article

References (57)

1. World Health Organization, Air Quality Guidelines of Europe, WHO, Copenhagen, 1987.
2. IARC, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, International Agency for Research on Cancer, Lyon, 1993.
3. IARC, Some Industrial Chemicals, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 60, International Agency for Research on Cancer, Lyon, 1994.
4. Norppa H., Mäki-Paakkanen J., Jantunen K., Einistö P., Räty R. Mutagenicity studies on styrene and vinyl acetate. Ann. N.Y. Acad. Sci. 534:1988;671-678.
5. Barale R. The genetic toxicology of styrene and styrene oxide. Mutat. Res. 257:1991;107-126.
6. Hemminki K., Vodička P. Styrene: from characterisation of DNA adducts to application in styrene-exposed lamination workers. Toxicol. Lett. 77:1995;153-161.
7. Tates A.D., Grummt T., Van Dam F.J., De Zwart F., Kasper F.J., Rothe R., Stirn H., Zwinderman A.H., Natarajan A.T. Measurement of frequencies of HPRT mutants, chromosomal aberrations, micronuclei, sister-chromatid exchanges and cells with high frequencies of SCEs in styrene/dichloromethane-exposed workers. Mutat. Res. 313:1994;249-262.
8. Savela K., Hesso A., Hemminki K. Characterization of reaction products between styrene oxide and deoxynucleotides and DNA. Chem.-Biol. Interact. 60:1986;235-246.
9. Vodička P., Hemminki K. Identification of alkylation products of styrene oxide in single- and double-stranded DNA. Carcinogenesis. 9:1988;1657-1660.
10. 32P -postlabelling detection of DNA adducts in mononuclear cells of workers occupationally exposed to styrene Carcinogenesis. 15:1994;1309-1315.
11. 32P -postlabelling of DNA adducts of styrene-exposed lamination workers Carcinogenesis. 14:1993;2059-2061.
12. 32P -postlabelling Carcinogenesis. 15:1994;1949-1953.
13. Pauwels W., Vodička P., Severi M., Plná K., Veulemans H., Hemminki K. Adduct formation on DNA and haemoglobin in mice intraperitoneally administered with styrene. Carcinogenesis. 17:1996;2673-2680.
14. Dypbukt J.M., Costa L.G., Manzo L., Orrenius S., Nicotera P. Cytotoxic and genotoxic effects of styrene-7,8-oxide in neuroadrenergic Pc 12 cells. Carcinogenesis. 13:1992;417-424.
15. Bastlová T., Vodička P., Peterková K., Hemminki K., Lambert B. Styrene oxide-induced HPRT mutations, DNA adducts and DNA strand breaks in cultured human lymphocytes. Carcinogenesis. 16:1995;2357-2362.
16. 32P -postlabelling in DNA and human embryonal lung fibroblasts (HEL) Carcinogenesis. 17:1996;801-808.
17. Mäki-Paakkanen J., Walles S., Osterman-Golkar S., Norppa H. Single-strand breaks, chromosome aberrations, sister-chromatid exchange, and micronuclei in blood lymphocytes of workers exposed to styrene during the production of reinforced plastics. Environ. Mol. Mutagen. 17:1991;27-31.
18. Walles S.A.S., Edling Ch., Anundi H., Johanson G. Exposure dependent increase in DNA single strand breaks in leucocytes from workers exposed to low concentrations of styrene. Br. J. Ind. Med. 50:1993;570-574.
19. Brenner D.D., Jeffrey A.M., Latriano L., Wazneh L., Warburton D., Toor M., Pero R.W., Andrews L.R., Walles S., Perera F.P. Biomarkers in styrene-exposed boatbuilders. Mutat. Res. 261:1991;225-236.
20. Singh N.P., McCoy L.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
21. Betti C., Davini T., Giannessi L., Loprieno N., Barale R. Microgel electrophoresis assay (Comet test) and SCE analysis in human lymphocytes from 100 normal subjects. Mutat. Res. 307:1994;323-333.
22. Christakopoulos A., Bergmark E., Zorcec V., Norppa H., Mäki-Paakkanen J., Osterman-Golkar S. Monitoring occupational exposure to styrene from haemoglobin adducts and metabolites in blood. Scand. J. Work Environ. Health. 19:1993;255-263.
23. Yeowell-O'Connell K., Jin Z., Rappaport S.M. Determination of albumin and haemoglobin adducts in workers exposed to styrene and styrene oxide. Cancer Epidemiol., Biomarkers Prev. 5:1996;205-215.
24. 6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis. 16:1995;1473-1481.
25. Bigbee W.L., Grant S.G., Langlois R.G., Jemsen R.H., Anttila A., Pfäffli P., Pekari K., Norppa H. Glycophorin A somatic cell mutation frequencies in Finnish reinforced plastic workers exposed to styrene. Cancer Epidemiol., Biomarkers Prev. 5:1996;801-810.
26. Frantík E., Beneš V. Central nervous effect and blood level regressions on exposure time parallel in solvents. Activ. Nerv. Super. 26:1984;131-133.
27. Mustonen R., Hemminki K. 7-Methylguanine levels in DNA of smokers' and nonsmokers' total white blood cells, granulocytes and lymphocytes. Carcinogenesis. 13:1992;1951-1955.
28. 32P -postlabelling method, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), Postlabelling Methods for Detection of DNA Adducts, International Agency for Research on Cancer, Lyon, 1993, pp. 51-63.
29. 32P -postlabelling test for structurally diverse DNA adducts Carcinogenesis. 7:1986;1543-1551.
30. 6-2′-deoxyguanosine 3′-monophosphate adducts of styrene oxide Chem.-Biol. Interact. 77:1991;39-50.
31. Pauwels W., Farmer P.B., Osterman-Golkar S., Severi M., Cordero R., Bailey E., Veulemans H. Ring test for the determination of N-terminal valine adducts of styrene 7,8-oxide on haemoglobin by the modified Edman degradation technique. J. Chromatogr., B. 702:1997;77-83.
32. Sugimura H., Caporaso N.E., Shaw G.L., Modali R.V., Gonzales F.J., Hoover R.N., Resau J.H., Trump B.F., Weston A., Harris C.C. Human debrisoquine hydroxylase gene polymorphism in cancer patients and controls. Carcinogenesis. 11:1990;1527-1530.
33. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450 1A1 gene. FEBS Lett. 263:1990;131-133.
34. Kato S., Shields P.G., Caporaso N.E., Sugimura H., Trivers G.E., Tucker M.A., Trump B.F., Weston A., Harris C.C. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol., Biomarkers Prev. 3:1994;515-518.
35. Persson I., Johansson I., Bergling H., Dahl M.-L., Seidergard J., Rylander R., Rannung A., Hogberg J., Ingelman-Sundberg M. Genetic polymorphism of cytochrome P450 2E1 in Swedish population. FEBS Lett. 319:1993;207-211.
36. P. Pfäffli, A. Säämänen, The occupational scene of styrene, in: M. Sorsa, K. Peltonen, H. Vainio, K. Hemminki (Eds.), Butadiene and Styrene: Assessment of Health Hazards, International Agency for Research on Cancer, Lyon, 1993, pp. 15-26.
37. Engström K., Härkönen H., Kalliokoski P., Rantanen J. Urinary mandelic acid concentration after occupational exposure to styrene and its use as a biological exposure test. Scand. J. Work Environ. Health. 21:1976;21-26.
38. Bartolucci G.B., De Rosa E., Gori G., Corona P.C., Perbellini L., Brugnone F. Biomonitoring of occupational exposure to styrene. Appl. Ind. Hyg. 1:1986;125-131.
39. Szyfter K., Hemminki K. Analysis of deoxyribonucleic acid adducts in workers. Scand. J. Work Environ. Health. 18:1992;22-26.
40. 32P -postlabelling assay Carcinogenesis. 12:1991;503-508.
41. Guengerich F.P., Kim D.H., Iwasaki M. Role of human cytochrome P-450 2E1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:1991;168-179.
42. Souček P., Gut I. Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica. 22:1992;83-103.
43. Hayashi S., Watanabe J., Nakachi K., Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J. Biochem. 110:1991;407-411.
44. Uematsu F., Kikuchi H., Motomiya M., Abe T., Sagami I., Ohmachi T., Wakui A., Kanamaru R., Watanabe M. Association between restriction fragment length polymorphism of the human cytochrome P450 2E1 gene and susceptibility to lung cancer. Jpn. J. Cancer Res. 82:1991;254-256.
45. Spitz M.R., Hoque A., Trizna Z., Schantz S.P., Amos C.I., King T.M., Bondy M.L., Hong W.K., Hsu T.C. Mutagen sensitivity as a risk factor for second malignant tumors following upper aerodigestive tract malignancies. J. Natl. Cancer Inst. 86:1994;1681-1684.
46. Spitz M.R., Hsu T.C., Wu X., Fueger J.J., Amos C.I., Roth J.A. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol., Biomarkers Prev. 4:1995;99-103.
47. Seree E.M., Villard P.H., Re J.L., De Meo M., Lacarelle B., Attolini L., Dumenil G., Catalin J., Durand A., Barra Y. High inducibility of mouse renal CYP2E1 gene by tobacco smoke and its possible effect on DNA single-strand breaks. Biochem. Biophys. Res. Commun. 219:1996;429-434.
48. Wu X., Shi H., Jiang H., Kemp B., Hong W.K., Spitz M.R. Associations between cytochrome P450 2E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis. 18:1997;967-973.
49. Saffhill R., Margison G.P., O'Connor P.J. Mechanisms of carcinogenesis induced by alkylating agents. Biochim. Biophys. Acta. 823:1985;111-145.
50. Robinson D.R., Goodall K., Albertini R.J., O'Neill J.P., Finette B., Sala-Trepat M., Moustacchi E., Tates A.D., Beare D.M., Green M.H.L., Cole J. An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets. Mutat. Res. 313:1994;227-247.
51. Tates A.D., Van Dam F.J., Van Mossel H., Schoemaker H., Thijssen J.C., Woldring V.M., Zwinderman A.H., Natarajan A.T. Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mutat. Res. 253:1991;199-213.
52. Michie C.A., McLean A., Alcock C., Beverley P.C.L. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 360:1992;264-265.
53. Hou S.-M., Fält S., Steen A.-M. HPRT mutant frequency and GSTM1 genotype in non-smoking healthy individuals. Environ. Mol. Mutagen. 25:1995;97-105.
54. Bastlová T., Podlutsky A. Molecular analysis of styrene oxide-induced hprt mutation in human T-lymphocytes. Mutagenesis. 11:1996;581-591.
55. 6-methylguanine paired with cytosine or thymine in defined oligonucleotide sequences. Biochemistry. 30:1991;11595-11599.
56. 6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea. Cancer Res. 55:1995;1875-1882.
57. Rappaport S.M., Yeowell-O'Connell K., Bodell W., Yager J.W., Symanski E. An investigation of multiple biomarkers among workers exposed to styrene and styrene-7,8-oxide. Cancer Res. 56:1996;5410-5416.